nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Lacrimation—Floxuridine—stomach cancer	0.0477	0.0847	CcSEcCtD
Naphazoline—NISCH—Paclitaxel—Docetaxel—stomach cancer	0.0379	1	CbGdCrCtD
Naphazoline—Lacrimation increased—Floxuridine—stomach cancer	0.0304	0.054	CcSEcCtD
Naphazoline—Punctate keratitis—Capecitabine—stomach cancer	0.0253	0.045	CcSEcCtD
Naphazoline—Ocular discomfort—Methotrexate—stomach cancer	0.021	0.0372	CcSEcCtD
Naphazoline—Lacrimation—Irinotecan—stomach cancer	0.0162	0.0289	CcSEcCtD
Naphazoline—Lacrimation—Fluorouracil—stomach cancer	0.0156	0.0276	CcSEcCtD
Naphazoline—Drowsiness—Mitomycin—stomach cancer	0.0123	0.0219	CcSEcCtD
Naphazoline—Erythema—Floxuridine—stomach cancer	0.0123	0.0218	CcSEcCtD
Naphazoline—Lacrimation—Docetaxel—stomach cancer	0.0112	0.02	CcSEcCtD
Naphazoline—Lacrimation increased—Irinotecan—stomach cancer	0.0104	0.0184	CcSEcCtD
Naphazoline—Discomfort—Floxuridine—stomach cancer	0.0103	0.0183	CcSEcCtD
Naphazoline—Lacrimation increased—Fluorouracil—stomach cancer	0.00993	0.0176	CcSEcCtD
Naphazoline—Keratitis—Capecitabine—stomach cancer	0.00986	0.0175	CcSEcCtD
Naphazoline—Redness—Docetaxel—stomach cancer	0.00978	0.0174	CcSEcCtD
Naphazoline—Erythema—Mitomycin—stomach cancer	0.00961	0.0171	CcSEcCtD
Naphazoline—Vision blurred—Mitomycin—stomach cancer	0.00906	0.0161	CcSEcCtD
Naphazoline—Hypertension—Mitomycin—stomach cancer	0.0083	0.0147	CcSEcCtD
Naphazoline—Discomfort—Mitomycin—stomach cancer	0.00809	0.0144	CcSEcCtD
Naphazoline—Lacrimation—Epirubicin—stomach cancer	0.00757	0.0135	CcSEcCtD
Naphazoline—Asthenia—Floxuridine—stomach cancer	0.00717	0.0127	CcSEcCtD
Naphazoline—Lacrimation increased—Docetaxel—stomach cancer	0.00716	0.0127	CcSEcCtD
Naphazoline—Lacrimation—Doxorubicin—stomach cancer	0.00701	0.0125	CcSEcCtD
Naphazoline—Somnolence—Mitomycin—stomach cancer	0.00698	0.0124	CcSEcCtD
Naphazoline—Lacrimation increased—Capecitabine—stomach cancer	0.00694	0.0123	CcSEcCtD
Naphazoline—Keratitis—Epirubicin—stomach cancer	0.00687	0.0122	CcSEcCtD
Naphazoline—Redness—Epirubicin—stomach cancer	0.0066	0.0117	CcSEcCtD
Naphazoline—Keratitis—Doxorubicin—stomach cancer	0.00635	0.0113	CcSEcCtD
Naphazoline—Headache—Floxuridine—stomach cancer	0.00626	0.0111	CcSEcCtD
Naphazoline—Redness—Doxorubicin—stomach cancer	0.0061	0.0108	CcSEcCtD
Naphazoline—Nausea—Floxuridine—stomach cancer	0.00594	0.0106	CcSEcCtD
Naphazoline—Asthenia—Mitomycin—stomach cancer	0.00563	0.01	CcSEcCtD
Naphazoline—Dizziness—Mitomycin—stomach cancer	0.00519	0.00922	CcSEcCtD
Naphazoline—Eye pain—Capecitabine—stomach cancer	0.00514	0.00913	CcSEcCtD
Naphazoline—Sweating—Irinotecan—stomach cancer	0.00512	0.0091	CcSEcCtD
Naphazoline—Headache—Mitomycin—stomach cancer	0.00492	0.00873	CcSEcCtD
Naphazoline—Lacrimation increased—Epirubicin—stomach cancer	0.00483	0.00859	CcSEcCtD
Naphazoline—Nausea—Mitomycin—stomach cancer	0.00466	0.00828	CcSEcCtD
Naphazoline—Lacrimation increased—Doxorubicin—stomach cancer	0.00447	0.00794	CcSEcCtD
Naphazoline—Erythema—Fluorouracil—stomach cancer	0.004	0.00711	CcSEcCtD
Naphazoline—Vision blurred—Fluorouracil—stomach cancer	0.00377	0.0067	CcSEcCtD
Naphazoline—Hyperglycaemia—Capecitabine—stomach cancer	0.00362	0.00643	CcSEcCtD
Naphazoline—Hypertension—Irinotecan—stomach cancer	0.0036	0.00641	CcSEcCtD
Naphazoline—Eye pain—Epirubicin—stomach cancer	0.00358	0.00636	CcSEcCtD
Naphazoline—Discomfort—Irinotecan—stomach cancer	0.00351	0.00624	CcSEcCtD
Naphazoline—Discomfort—Fluorouracil—stomach cancer	0.00336	0.00598	CcSEcCtD
Naphazoline—Eye pain—Doxorubicin—stomach cancer	0.00331	0.00589	CcSEcCtD
Naphazoline—Hyperhidrosis—Irinotecan—stomach cancer	0.00329	0.00585	CcSEcCtD
Naphazoline—Eye disorder—Docetaxel—stomach cancer	0.0031	0.00551	CcSEcCtD
Naphazoline—Somnolence—Irinotecan—stomach cancer	0.00303	0.00538	CcSEcCtD
Naphazoline—Eye disorder—Capecitabine—stomach cancer	0.003	0.00533	CcSEcCtD
Naphazoline—Somnolence—Fluorouracil—stomach cancer	0.0029	0.00516	CcSEcCtD
Naphazoline—Erythema—Docetaxel—stomach cancer	0.00289	0.00513	CcSEcCtD
Naphazoline—Erythema—Capecitabine—stomach cancer	0.00279	0.00497	CcSEcCtD
Naphazoline—Drowsiness—Methotrexate—stomach cancer	0.00266	0.00473	CcSEcCtD
Naphazoline—Vision blurred—Capecitabine—stomach cancer	0.00263	0.00468	CcSEcCtD
Naphazoline—Sweating—Methotrexate—stomach cancer	0.00255	0.00453	CcSEcCtD
Naphazoline—Hyperglycaemia—Epirubicin—stomach cancer	0.00252	0.00448	CcSEcCtD
Naphazoline—Hypertension—Docetaxel—stomach cancer	0.00249	0.00443	CcSEcCtD
Naphazoline—Drowsiness—Epirubicin—stomach cancer	0.00249	0.00443	CcSEcCtD
Naphazoline—Asthenia—Irinotecan—stomach cancer	0.00244	0.00434	CcSEcCtD
Naphazoline—Hypertension—Capecitabine—stomach cancer	0.00241	0.00429	CcSEcCtD
Naphazoline—Sweating—Epirubicin—stomach cancer	0.00239	0.00424	CcSEcCtD
Naphazoline—Discomfort—Capecitabine—stomach cancer	0.00235	0.00418	CcSEcCtD
Naphazoline—Hyperglycaemia—Doxorubicin—stomach cancer	0.00233	0.00414	CcSEcCtD
Naphazoline—Drowsiness—Doxorubicin—stomach cancer	0.00231	0.0041	CcSEcCtD
Naphazoline—Dizziness—Irinotecan—stomach cancer	0.00225	0.004	CcSEcCtD
Naphazoline—Eye disorder—Methotrexate—stomach cancer	0.00223	0.00397	CcSEcCtD
Naphazoline—Sweating—Doxorubicin—stomach cancer	0.00221	0.00393	CcSEcCtD
Naphazoline—Hyperhidrosis—Capecitabine—stomach cancer	0.0022	0.00392	CcSEcCtD
Naphazoline—Dizziness—Fluorouracil—stomach cancer	0.00216	0.00383	CcSEcCtD
Naphazoline—Headache—Irinotecan—stomach cancer	0.00213	0.00379	CcSEcCtD
Naphazoline—Somnolence—Docetaxel—stomach cancer	0.00209	0.00372	CcSEcCtD
Naphazoline—Eye disorder—Epirubicin—stomach cancer	0.00209	0.00371	CcSEcCtD
Naphazoline—Erythema—Methotrexate—stomach cancer	0.00208	0.0037	CcSEcCtD
Naphazoline—Headache—Fluorouracil—stomach cancer	0.00204	0.00363	CcSEcCtD
Naphazoline—Nausea—Irinotecan—stomach cancer	0.00202	0.0036	CcSEcCtD
Naphazoline—Vision blurred—Methotrexate—stomach cancer	0.00196	0.00348	CcSEcCtD
Naphazoline—Erythema—Epirubicin—stomach cancer	0.00195	0.00346	CcSEcCtD
Naphazoline—Nausea—Fluorouracil—stomach cancer	0.00194	0.00344	CcSEcCtD
Naphazoline—Eye disorder—Doxorubicin—stomach cancer	0.00193	0.00344	CcSEcCtD
Naphazoline—Tension—Epirubicin—stomach cancer	0.00191	0.00339	CcSEcCtD
Naphazoline—Nervousness—Epirubicin—stomach cancer	0.00189	0.00336	CcSEcCtD
Naphazoline—Vision blurred—Epirubicin—stomach cancer	0.00183	0.00326	CcSEcCtD
Naphazoline—Erythema—Doxorubicin—stomach cancer	0.0018	0.0032	CcSEcCtD
Naphazoline—Tension—Doxorubicin—stomach cancer	0.00177	0.00314	CcSEcCtD
Naphazoline—Discomfort—Methotrexate—stomach cancer	0.00175	0.00311	CcSEcCtD
Naphazoline—Nervousness—Doxorubicin—stomach cancer	0.00175	0.00311	CcSEcCtD
Naphazoline—Vision blurred—Doxorubicin—stomach cancer	0.0017	0.00302	CcSEcCtD
Naphazoline—Asthenia—Docetaxel—stomach cancer	0.00169	0.003	CcSEcCtD
Naphazoline—Hypertension—Epirubicin—stomach cancer	0.00168	0.00299	CcSEcCtD
Naphazoline—Hyperhidrosis—Methotrexate—stomach cancer	0.00164	0.00292	CcSEcCtD
Naphazoline—Discomfort—Epirubicin—stomach cancer	0.00164	0.00291	CcSEcCtD
Naphazoline—Asthenia—Capecitabine—stomach cancer	0.00164	0.00291	CcSEcCtD
Naphazoline—Dizziness—Docetaxel—stomach cancer	0.00156	0.00277	CcSEcCtD
Naphazoline—Hypertension—Doxorubicin—stomach cancer	0.00156	0.00276	CcSEcCtD
Naphazoline—Hyperhidrosis—Epirubicin—stomach cancer	0.00154	0.00273	CcSEcCtD
Naphazoline—Discomfort—Doxorubicin—stomach cancer	0.00152	0.00269	CcSEcCtD
Naphazoline—Somnolence—Methotrexate—stomach cancer	0.00151	0.00268	CcSEcCtD
Naphazoline—Dizziness—Capecitabine—stomach cancer	0.00151	0.00268	CcSEcCtD
Naphazoline—Headache—Docetaxel—stomach cancer	0.00148	0.00262	CcSEcCtD
Naphazoline—Headache—Capecitabine—stomach cancer	0.00143	0.00254	CcSEcCtD
Naphazoline—Hyperhidrosis—Doxorubicin—stomach cancer	0.00142	0.00253	CcSEcCtD
Naphazoline—Somnolence—Epirubicin—stomach cancer	0.00141	0.00251	CcSEcCtD
Naphazoline—Nausea—Docetaxel—stomach cancer	0.0014	0.00249	CcSEcCtD
Naphazoline—Nausea—Capecitabine—stomach cancer	0.00135	0.00241	CcSEcCtD
Naphazoline—Somnolence—Doxorubicin—stomach cancer	0.00131	0.00232	CcSEcCtD
Naphazoline—Asthenia—Methotrexate—stomach cancer	0.00122	0.00216	CcSEcCtD
Naphazoline—Asthenia—Epirubicin—stomach cancer	0.00114	0.00203	CcSEcCtD
Naphazoline—Dizziness—Methotrexate—stomach cancer	0.00112	0.00199	CcSEcCtD
Naphazoline—Headache—Methotrexate—stomach cancer	0.00106	0.00189	CcSEcCtD
Naphazoline—Asthenia—Doxorubicin—stomach cancer	0.00105	0.00187	CcSEcCtD
Naphazoline—Dizziness—Epirubicin—stomach cancer	0.00105	0.00187	CcSEcCtD
Naphazoline—Propranolol—ADRB1—stomach cancer	0.00104	0.366	CrCbGaD
Naphazoline—Nausea—Methotrexate—stomach cancer	0.00101	0.00179	CcSEcCtD
Naphazoline—Headache—Epirubicin—stomach cancer	0.000995	0.00177	CcSEcCtD
Naphazoline—Dizziness—Doxorubicin—stomach cancer	0.000972	0.00173	CcSEcCtD
Naphazoline—Nausea—Epirubicin—stomach cancer	0.000944	0.00168	CcSEcCtD
Naphazoline—Propranolol—HTR1A—stomach cancer	0.000933	0.327	CrCbGaD
Naphazoline—Headache—Doxorubicin—stomach cancer	0.000921	0.00164	CcSEcCtD
Naphazoline—Propranolol—ADRB2—stomach cancer	0.000877	0.307	CrCbGaD
Naphazoline—Nausea—Doxorubicin—stomach cancer	0.000873	0.00155	CcSEcCtD
Naphazoline—ADRA1A—Signaling Pathways—ANXA1—stomach cancer	0.000112	0.000282	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HSPB1—stomach cancer	0.000112	0.000282	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGTR2—stomach cancer	0.000112	0.000282	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6R—stomach cancer	0.000111	0.00028	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—F2R—stomach cancer	0.000111	0.000279	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—BMP2—stomach cancer	0.000111	0.000279	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—RHOA—stomach cancer	0.00011	0.000278	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—MAPK3—stomach cancer	0.00011	0.000277	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HBEGF—stomach cancer	0.000109	0.000274	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKR1C3—stomach cancer	0.000109	0.000274	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRB1—stomach cancer	0.000108	0.000273	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR1A—stomach cancer	0.000108	0.000271	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRB2—stomach cancer	0.000107	0.000271	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—TYMS—stomach cancer	0.000107	0.000271	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GSTM1—stomach cancer	0.000106	0.000268	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—KRAS—stomach cancer	0.000106	0.000267	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PPP2R1A—stomach cancer	0.000105	0.000266	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—MAPK1—stomach cancer	0.000105	0.000264	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PRKCB—stomach cancer	0.000104	0.000263	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ANXA1—stomach cancer	0.000104	0.000262	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6R—stomach cancer	0.000104	0.000261	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RPS6—stomach cancer	0.000104	0.000261	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—RHOA—stomach cancer	0.000103	0.00026	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PRKCB—stomach cancer	0.000102	0.000257	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6ST—stomach cancer	0.000101	0.000256	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRB1—stomach cancer	0.000101	0.000254	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRB2—stomach cancer	0.0001	0.000253	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—RHOA—stomach cancer	0.0001	0.000253	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ERCC2—stomach cancer	9.97e-05	0.000252	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—KRAS—stomach cancer	9.88e-05	0.000249	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PPP2R1A—stomach cancer	9.84e-05	0.000248	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SMAD4—stomach cancer	9.78e-05	0.000247	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—PIK3CA—stomach cancer	9.71e-05	0.000245	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CXCL8—stomach cancer	9.68e-05	0.000244	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RPS6—stomach cancer	9.62e-05	0.000243	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPP2R1A—stomach cancer	9.56e-05	0.000241	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HBEGF—stomach cancer	9.51e-05	0.00024	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PRKCB—stomach cancer	9.46e-05	0.000239	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—VEGFA—stomach cancer	9.44e-05	0.000238	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6ST—stomach cancer	9.42e-05	0.000238	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TP53—stomach cancer	9.4e-05	0.000237	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GSTP1—stomach cancer	9.38e-05	0.000237	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—MTHFR—stomach cancer	9.37e-05	0.000236	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—RHOA—stomach cancer	9.35e-05	0.000236	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FYN—stomach cancer	9.29e-05	0.000234	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—HMOX1—stomach cancer	9.25e-05	0.000233	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SMAD4—stomach cancer	9.14e-05	0.00023	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—PIK3CA—stomach cancer	9.07e-05	0.000229	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6R—stomach cancer	9.05e-05	0.000228	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CXCL8—stomach cancer	9.04e-05	0.000228	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—RHOA—stomach cancer	9e-05	0.000227	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—HRAS—stomach cancer	8.99e-05	0.000227	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—MAPK3—stomach cancer	8.93e-05	0.000225	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HBEGF—stomach cancer	8.84e-05	0.000223	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CXCL8—stomach cancer	8.79e-05	0.000222	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TP53—stomach cancer	8.78e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRB2—stomach cancer	8.78e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FGFR2—stomach cancer	8.72e-05	0.00022	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—TYMS—stomach cancer	8.72e-05	0.00022	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FYN—stomach cancer	8.67e-05	0.000219	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CAV1—stomach cancer	8.65e-05	0.000218	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—APOA1—stomach cancer	8.63e-05	0.000218	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GSTM1—stomach cancer	8.62e-05	0.000217	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PPP2R1A—stomach cancer	8.6e-05	0.000217	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—MAPK1—stomach cancer	8.49e-05	0.000214	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6R—stomach cancer	8.41e-05	0.000212	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—HRAS—stomach cancer	8.4e-05	0.000212	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—RHOA—stomach cancer	8.36e-05	0.000211	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCL8—stomach cancer	8.21e-05	0.000207	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—RHOA—stomach cancer	8.17e-05	0.000206	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRB2—stomach cancer	8.16e-05	0.000206	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FGFR2—stomach cancer	8.14e-05	0.000205	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ERCC2—stomach cancer	8.1e-05	0.000204	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—KRAS—stomach cancer	8.02e-05	0.000202	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PPP2R1A—stomach cancer	7.99e-05	0.000202	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	7.99e-05	0.000201	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IRS2—stomach cancer	7.98e-05	0.000201	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	7.9e-05	0.000199	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CAV1—stomach cancer	7.74e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOA1—stomach cancer	7.72e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MTHFR—stomach cancer	7.61e-05	0.000192	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPARG—stomach cancer	7.6e-05	0.000192	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—RHOA—stomach cancer	7.6e-05	0.000192	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FYN—stomach cancer	7.58e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IRS2—stomach cancer	7.46e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	7.42e-05	0.000187	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—PIK3CA—stomach cancer	7.37e-05	0.000186	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PRKCB—stomach cancer	7.37e-05	0.000186	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	7.34e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6ST—stomach cancer	7.34e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CAV1—stomach cancer	7.23e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOA1—stomach cancer	7.21e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	7.18e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TP53—stomach cancer	7.13e-05	0.00018	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	7.12e-05	0.00018	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APC—stomach cancer	7.05e-05	0.000178	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FYN—stomach cancer	7.05e-05	0.000178	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CAV1—stomach cancer	7.02e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOA1—stomach cancer	7.01e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PRKCB—stomach cancer	6.88e-05	0.000174	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6ST—stomach cancer	6.85e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALB—stomach cancer	6.84e-05	0.000172	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—HRAS—stomach cancer	6.82e-05	0.000172	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—MAPK3—stomach cancer	6.75e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	6.67e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	6.61e-05	0.000167	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APC—stomach cancer	6.59e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6R—stomach cancer	6.55e-05	0.000165	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—NOS3—stomach cancer	6.54e-05	0.000165	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IRS2—stomach cancer	6.52e-05	0.000164	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—MAPK1—stomach cancer	6.42e-05	0.000162	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—EGFR—stomach cancer	6.42e-05	0.000162	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CAV1—stomach cancer	6.32e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—MAPK3—stomach cancer	6.31e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOA1—stomach cancer	6.31e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARG—stomach cancer	6.17e-05	0.000156	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—PIK3CA—stomach cancer	6.14e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SERPINE1—stomach cancer	6.13e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6R—stomach cancer	6.12e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—KRAS—stomach cancer	6.07e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IRS2—stomach cancer	6.06e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	6.02e-05	0.000152	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—MAPK1—stomach cancer	6e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—EGFR—stomach cancer	6e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	5.99e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—stomach cancer	5.98e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RHOA—stomach cancer	5.91e-05	0.000149	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CAV1—stomach cancer	5.87e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOA1—stomach cancer	5.86e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOS3—stomach cancer	5.85e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APC—stomach cancer	5.76e-05	0.000145	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PIK3CA—stomach cancer	5.73e-05	0.000145	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SERPINE1—stomach cancer	5.73e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—KRAS—stomach cancer	5.67e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	5.59e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	5.58e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	5.57e-05	0.00014	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALB—stomach cancer	5.55e-05	0.00014	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RHOA—stomach cancer	5.52e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	5.51e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	5.47e-05	0.000138	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOS3—stomach cancer	5.47e-05	0.000138	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APC—stomach cancer	5.35e-05	0.000135	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6R—stomach cancer	5.35e-05	0.000135	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NOS3—stomach cancer	5.31e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	5.25e-05	0.000132	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	5.25e-05	0.000132	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PIK3CA—stomach cancer	5.21e-05	0.000131	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	5.19e-05	0.000131	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	5.16e-05	0.00013	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	5.12e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ERBB2—stomach cancer	5.11e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	5.07e-05	0.000128	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	5.01e-05	0.000126	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	5.01e-05	0.000126	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6R—stomach cancer	4.97e-05	0.000125	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	4.96e-05	0.000125	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—stomach cancer	4.94e-05	0.000125	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	4.87e-05	0.000123	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	4.87e-05	0.000123	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—stomach cancer	4.86e-05	0.000123	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	4.85e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCND1—stomach cancer	4.84e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RHOA—stomach cancer	4.83e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—JUN—stomach cancer	4.83e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	4.82e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOS3—stomach cancer	4.78e-05	0.000121	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	4.74e-05	0.000119	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—stomach cancer	4.7e-05	0.000118	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	4.68e-05	0.000118	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	4.66e-05	0.000118	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	4.65e-05	0.000117	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—stomach cancer	4.61e-05	0.000116	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	4.6e-05	0.000116	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	4.57e-05	0.000115	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	4.55e-05	0.000115	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCND1—stomach cancer	4.52e-05	0.000114	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—JUN—stomach cancer	4.51e-05	0.000114	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RHOA—stomach cancer	4.49e-05	0.000113	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	4.47e-05	0.000113	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOS3—stomach cancer	4.44e-05	0.000112	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—stomach cancer	4.39e-05	0.000111	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	4.37e-05	0.00011	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	4.27e-05	0.000108	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	4.24e-05	0.000107	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	4.23e-05	0.000107	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	4.22e-05	0.000106	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	4.21e-05	0.000106	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—STAT3—stomach cancer	4.18e-05	0.000105	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	4.15e-05	0.000105	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	4.14e-05	0.000104	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—stomach cancer	4.03e-05	0.000102	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	3.99e-05	0.000101	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCND1—stomach cancer	3.95e-05	9.96e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—JUN—stomach cancer	3.94e-05	9.94e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	3.94e-05	9.94e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	3.94e-05	9.94e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	3.91e-05	9.87e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—STAT3—stomach cancer	3.9e-05	9.84e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MYC—stomach cancer	3.88e-05	9.79e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	3.85e-05	9.7e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—stomach cancer	3.83e-05	9.67e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	3.82e-05	9.64e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	3.8e-05	9.57e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGFR—stomach cancer	3.79e-05	9.57e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—stomach cancer	3.75e-05	9.45e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	3.73e-05	9.41e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	3.73e-05	9.4e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CA—stomach cancer	3.68e-05	9.28e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCND1—stomach cancer	3.67e-05	9.26e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—JUN—stomach cancer	3.66e-05	9.24e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MYC—stomach cancer	3.62e-05	9.14e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KRAS—stomach cancer	3.58e-05	9.04e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—stomach cancer	3.56e-05	8.99e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	3.55e-05	8.96e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	3.55e-05	8.94e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGFR—stomach cancer	3.54e-05	8.94e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	3.47e-05	8.74e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	3.44e-05	8.69e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—STAT3—stomach cancer	3.41e-05	8.6e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KRAS—stomach cancer	3.35e-05	8.45e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	3.29e-05	8.31e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	3.26e-05	8.22e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	3.2e-05	8.07e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TP53—stomach cancer	3.19e-05	8.04e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MYC—stomach cancer	3.17e-05	7.99e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STAT3—stomach cancer	3.17e-05	7.99e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	3.1e-05	7.82e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGFR—stomach cancer	3.1e-05	7.82e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	3.08e-05	7.76e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HRAS—stomach cancer	3.05e-05	7.69e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	3.03e-05	7.63e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CA—stomach cancer	2.99e-05	7.54e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TP53—stomach cancer	2.98e-05	7.51e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MYC—stomach cancer	2.94e-05	7.43e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KRAS—stomach cancer	2.93e-05	7.38e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—stomach cancer	2.92e-05	7.36e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	2.88e-05	7.26e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGFR—stomach cancer	2.88e-05	7.26e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HRAS—stomach cancer	2.85e-05	7.18e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—stomach cancer	2.72e-05	6.87e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KRAS—stomach cancer	2.72e-05	6.86e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	2.69e-05	6.78e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TP53—stomach cancer	2.6e-05	6.56e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	2.5e-05	6.3e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HRAS—stomach cancer	2.49e-05	6.28e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TP53—stomach cancer	2.42e-05	6.1e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—stomach cancer	2.38e-05	6.01e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HRAS—stomach cancer	2.31e-05	5.83e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—stomach cancer	2.21e-05	5.58e-05	CbGpPWpGaD
